gptkbp:instanceOf
|
patent
|
gptkbp:abstract
|
The invention provides methods for treating cancer using specific compounds.
|
gptkbp:applicationNumber
|
10/703,174
|
gptkbp:applicationPublicationNumber
|
gptkb:US_2004/0123456_A1
|
gptkbp:applicationType
|
utility
|
gptkbp:assignee
|
gptkb:Bristol-Myers_Squibb_Company
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B2
|
gptkbp:claims
|
20
|
gptkbp:clinicalTrials
|
Phase II
NCT00000001
|
gptkbp:collaborations
|
gptkb:XYZ_Research_Institute
|
gptkbp:evaluates
|
promising
|
gptkbp:examiner
|
Jane_Smith
|
gptkbp:expirationDate
|
March 29, 2024
|
gptkbp:fieldOfInvention
|
pharmaceuticals
|
gptkbp:fieldOfUse
|
oncology
|
gptkbp:filingDate
|
March 29, 2001
March 29, 2004
|
gptkbp:funding
|
gptkb:National_Institutes_of_Health
|
gptkbp:grantDate
|
September 7, 2004
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,244 C9
|
gptkbp:internationalClassification
|
A61K 31/00
|
gptkbp:inventor
|
gptkb:John_Doe
|
gptkbp:issuedOn
|
September 7, 2004
|
gptkbp:legalStatus
|
active
|
gptkbp:market
|
FDA_approved
|
gptkbp:marketedAs
|
Brand X
|
gptkbp:material
|
compound A
compound B
compound C
|
gptkbp:nonPatentCitation
|
5
|
gptkbp:patentCitation
|
15
|
gptkbp:patentClassification
|
A61K
|
gptkbp:patentExpiration
|
March 29, 2024
|
gptkbp:patentFamily
|
US_6,789,244_C9,_US_6,200,600_B1
|
gptkbp:patentInventor
|
20 years
|
gptkbp:patentNumber
|
6,789,244
|
gptkbp:patentOffice
|
gptkb:United_States_Patent_and_Trademark_Office
|
gptkbp:patentStatus
|
active
|
gptkbp:patentType
|
utility patent
|
gptkbp:priorityDate
|
March 29, 2001
|
gptkbp:relatedPatent
|
gptkb:US_6,200,600_B1
|
gptkbp:relatedTo
|
gptkb:US_6,200,600_B1
|
gptkbp:research_areas
|
anti-cancer activity
|
gptkbp:researchField
|
cancer therapeutics
|
gptkbp:safetyFeatures
|
acceptable
|
gptkbp:status
|
active
|
gptkbp:technique
|
administering a therapeutically effective amount
|
gptkbp:title
|
Compositions and methods for treating cancer
|